Where we are
Our highly experienced team of experts supports a comprehensive network of 26 strategically located offices throughout Europe. This puts a population of more than 500 million people within reach of your study, and we are currently running 250 active trials in 38 different countries.
Our current geographical presence
Optimapharm has 26 offices in Europe. The Company also runs operations in 11 other European countries and Israel. Optimapharm is currently broadening its Global Footprint. See the map below for more details:
The benefits of a pan- European
As a leading pan-European CRO, we can provide unrivalled access to the motivated investigators and participant rich territories of Central, Eastern and South-Eastern Europe. This is an important factor in our ability to reliably expedite patient recruitment and deliver accurate results to clinical research projects in a cost effective and timely manner.
Our established footholds in Western Europe’s and Nordic’s more mature markets mean we can accommodate trials with a broad geographic and demographic spread. They also help to facilitate high quality post-launch and real-world evidence studies as well furnishing projects with a larger population of potential participants for less common therapeutic areas.
We are also capable of leading or participating in combined regions studies with a network of strategic partnerships that covers regions outside of Europe including the USA, Russia and Australia.